![Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations: Molecular Therapy - Nucleic Acids Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/c9d6e623-263f-498e-8567-fd222546f933/fx1.jpg)
Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations: Molecular Therapy - Nucleic Acids
Dravet Syndrome Foundation - Help DSF raise awarenesss of SUDEP worldwide today for SUDEP Action Day http://sudepactionday.org/ | Facebook
![The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome - ScienceDirect The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525505014006982-gr1.jpg)
The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome - ScienceDirect
![Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome | eNeuro Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome | eNeuro](https://www.eneuro.org/content/9/5/ENEURO.0112-22.2022/F1.large.jpg)